Logo image of SJ

SCIENJOY HOLDING CORP-A (SJ) Stock Fundamental Analysis

USA - NASDAQ:SJ - VGG7864D1125 - Common Stock

0.544 USD
+0.02 (+4.62%)
Last: 10/20/2025, 8:16:21 PM
0.534 USD
-0.01 (-1.84%)
Pre-Market: 10/21/2025, 4:17:53 AM
Fundamental Rating

5

Taking everything into account, SJ scores 5 out of 10 in our fundamental rating. SJ was compared to 80 industry peers in the Entertainment industry. SJ has an excellent financial health rating, but there are some minor concerns on its profitability. SJ is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year SJ was profitable.
In the past year SJ had a positive cash flow from operations.
SJ had positive earnings in 4 of the past 5 years.
SJ had a positive operating cash flow in each of the past 5 years.
SJ Yearly Net Income VS EBIT VS OCF VS FCFSJ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

SJ has a Return On Assets of 0.79%. This is comparable to the rest of the industry: SJ outperforms 60.00% of its industry peers.
SJ has a Return On Equity of 0.92%. This is in the better half of the industry: SJ outperforms 62.50% of its industry peers.
With a decent Return On Invested Capital value of 2.07%, SJ is doing good in the industry, outperforming 62.50% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SJ is significantly below the industry average of 9.23%.
Industry RankSector Rank
ROA 0.79%
ROE 0.92%
ROIC 2.07%
ROA(3y)4.52%
ROA(5y)10.17%
ROE(3y)5.76%
ROE(5y)15.32%
ROIC(3y)3.9%
ROIC(5y)9.89%
SJ Yearly ROA, ROE, ROICSJ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

Looking at the Profit Margin, with a value of 0.85%, SJ is in line with its industry, outperforming 60.00% of the companies in the same industry.
SJ's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 2.92%, SJ is doing good in the industry, outperforming 61.25% of the companies in the same industry.
SJ's Operating Margin has declined in the last couple of years.
SJ's Gross Margin of 18.88% is on the low side compared to the rest of the industry. SJ is outperformed by 78.75% of its industry peers.
In the last couple of years the Gross Margin of SJ has declined.
Industry RankSector Rank
OM 2.92%
PM (TTM) 0.85%
GM 18.88%
OM growth 3Y-33.03%
OM growth 5Y-29.41%
PM growth 3Y-34.13%
PM growth 5Y-29.22%
GM growth 3Y-0.44%
GM growth 5Y-3.23%
SJ Yearly Profit, Operating, Gross MarginsSJ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SJ is destroying value.
SJ has more shares outstanding than it did 1 year ago.
SJ has more shares outstanding than it did 5 years ago.
There is no outstanding debt for SJ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SJ Yearly Shares OutstandingSJ Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SJ Yearly Total Debt VS Total AssetsSJ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.52 indicates that SJ is not a great score, but indicates only limited risk for bankruptcy at the moment.
SJ has a Altman-Z score of 2.52. This is in the better half of the industry: SJ outperforms 70.00% of its industry peers.
There is no outstanding debt for SJ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.52
ROIC/WACC0.28
WACC7.54%
SJ Yearly LT Debt VS Equity VS FCFSJ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

SJ has a Current Ratio of 3.48. This indicates that SJ is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.48, SJ belongs to the best of the industry, outperforming 91.25% of the companies in the same industry.
A Quick Ratio of 3.48 indicates that SJ has no problem at all paying its short term obligations.
SJ's Quick ratio of 3.48 is amongst the best of the industry. SJ outperforms 91.25% of its industry peers.
Industry RankSector Rank
Current Ratio 3.48
Quick Ratio 3.48
SJ Yearly Current Assets VS Current LiabilitesSJ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

SJ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 115.55%, which is quite impressive.
The earnings per share for SJ have been decreasing by -28.33% on average. This is quite bad
SJ shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.75%.
Measured over the past years, SJ shows a quite strong growth in Revenue. The Revenue has been growing by 8.31% on average per year.
EPS 1Y (TTM)115.55%
EPS 3Y-44.25%
EPS 5Y-28.33%
EPS Q2Q%-36.61%
Revenue 1Y (TTM)-10.75%
Revenue growth 3Y-6.53%
Revenue growth 5Y8.31%
Sales Q2Q%-6.89%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SJ Yearly Revenue VS EstimatesSJ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.60 indicates a correct valuation of SJ.
Based on the Price/Earnings ratio, SJ is valued cheaper than 86.25% of the companies in the same industry.
When comparing the Price/Earnings ratio of SJ to the average of the S&P500 Index (27.69), we can say SJ is valued rather cheaply.
Industry RankSector Rank
PE 13.6
Fwd PE N/A
SJ Price Earnings VS Forward Price EarningsSJ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than SJ, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.39
EV/EBITDA -2.72
SJ Per share dataSJ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SJ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCIENJOY HOLDING CORP-A

NASDAQ:SJ (10/20/2025, 8:16:21 PM)

Premarket: 0.534 -0.01 (-1.84%)

0.544

+0.02 (+4.62%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-20 2025-08-20
Earnings (Next)11-24 2025-11-24
Inst Owners0.36%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap23.03M
Analysts0
Price TargetN/A
Short Float %0.02%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.6
Fwd PE N/A
P/S 0.12
P/FCF 1.39
P/OCF 1.37
P/B 0.13
P/tB 0.26
EV/EBITDA -2.72
EPS(TTM)0.04
EY7.35%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.39
FCFY72.13%
OCF(TTM)0.4
OCFY72.73%
SpS4.41
BVpS4.04
TBVpS2.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.79%
ROE 0.92%
ROCE 3.05%
ROIC 2.07%
ROICexc 2.73%
ROICexgc 6.91%
OM 2.92%
PM (TTM) 0.85%
GM 18.88%
FCFM 8.91%
ROA(3y)4.52%
ROA(5y)10.17%
ROE(3y)5.76%
ROE(5y)15.32%
ROIC(3y)3.9%
ROIC(5y)9.89%
ROICexc(3y)4.8%
ROICexc(5y)15.26%
ROICexgc(3y)11.69%
ROICexgc(5y)N/A
ROCE(3y)5.76%
ROCE(5y)14.57%
ROICexcg growth 3Y-44.13%
ROICexcg growth 5Y-50.35%
ROICexc growth 3Y-46.72%
ROICexc growth 5Y-58.97%
OM growth 3Y-33.03%
OM growth 5Y-29.41%
PM growth 3Y-34.13%
PM growth 5Y-29.22%
GM growth 3Y-0.44%
GM growth 5Y-3.23%
F-Score7
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 6.41%
Cap/Sales 0.07%
Interest Coverage 250
Cash Conversion 219.87%
Profit Quality 1051.23%
Current Ratio 3.48
Quick Ratio 3.48
Altman-Z 2.52
F-Score7
WACC7.54%
ROIC/WACC0.28
Cap/Depr(3y)12.27%
Cap/Depr(5y)22.76%
Cap/Sales(3y)0.07%
Cap/Sales(5y)0.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)115.55%
EPS 3Y-44.25%
EPS 5Y-28.33%
EPS Q2Q%-36.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.75%
Revenue growth 3Y-6.53%
Revenue growth 5Y8.31%
Sales Q2Q%-6.89%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.16%
EBIT growth 3Y-37.4%
EBIT growth 5Y-23.55%
EBIT Next Year714.3%
EBIT Next 3Y173.29%
EBIT Next 5Y128.25%
FCF growth 1Y-33.73%
FCF growth 3Y-16.15%
FCF growth 5Y-21.58%
OCF growth 1Y-33.09%
OCF growth 3Y-16.09%
OCF growth 5Y-21.39%